We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress
Sign In
Advertise with Us
BIO-RAD LABORATORIES

Download Mobile App




New Blood Test Could Ensure Timely Life-Saving Treatment of Heart Attack Victims

By LabMedica International staff writers
Posted on 02 Feb 2023
Print article
Image: The new blood test measures stress hormone levels after heart attacks (Photo courtesy of University of Oxford)
Image: The new blood test measures stress hormone levels after heart attacks (Photo courtesy of University of Oxford)

Cardiovascular disease, one of the leading causes of death, generally manifests itself through heart attacks. Most patients with very large heart attacks are treated using an emergency procedure called primary percutaneous coronary intervention (PCI). Some of these patients do very well after the procedure but about a third do not. Now, new research shows that routine testing for a stress hormone Neuropeptide Y (NPY) in the hours following a heart attack could save thousands of lives.

In the new study, researchers at University of Oxford (Oxford, UK) investigated NPY levels in the blood of 163 heart attack patients who had been given emergency treatment to open up a blocked blood vessel. Once NPY is released into the heart, it causes the smallest blood vessels to narrow. The researchers found that in patients with the highest NPY levels, the smallest blood vessels in their heart remained narrowed two days after a heart attack. MRI scans performed after six months showed more scarring in the hearts of these patients, resulting in the inability to pump blood efficiently.

The researchers also measured NPY levels in standard blood samples obtained from the veins of patients when they were given PCI treatment. The researchers found more heart and lung damage in patients having the highest NPY levels and their hearts were much more likely to fail irrespective of other risk factors over the subsequent six years. During follow-ups, 34 patients died or suffered from heart failure. Based on these findings, the researchers concluded that routine tests conducted in the hours following a heart attack could more quickly identify patients facing the highest risk and prioritize them for treatment.

“Our previous research has shown that NPY is raised during a heart attack and local levels within the heart correlate with how well it recovers,” said Neil Herring, Associate Professor and lead researcher. “What this new study adds is that high NPY levels, even when measured through a standard blood test from a vein, predict which patients go on to develop heart failure or die. This provides extremely useful information for doctors and we hope that developing drugs that target the receptors NPY acts on may really be game changing for this cohort of patients and the blood test could help spot those patients who may need it right from the start.”

“This study identifies a ‘cut off’ value for the blood test which helps identify those patients that do badly after their large heart attack. Ideally, further studies should then test this cut off level in a different group of patients to ensure that it is robust in predicting heart failure and death. However, if successful, then it could be offered to all patients with large heart attacks undergoing emergency treatment,” added Prof. Herring. “We’re confident that, in time, this stress hormone will become an effective target for future treatments to reduce the life-limiting effects of a heart attack.”

Related Links:
University of Oxford 

Platinum Member
COVID-19 Rapid Test
OSOM COVID-19 Antigen Rapid Test
Magnetic Bead Separation Modules
MAG and HEATMAG
POCT Fluorescent Immunoassay Analyzer
FIA Go
Gold Member
ADAMTS-13 Protease Activity Test
ATS-13 Activity Assay

Print article

Channels

Clinical Chemistry

view channel
Image: The 3D printed miniature ionizer is a key component of a mass spectrometer (Photo courtesy of MIT)

3D Printed Point-Of-Care Mass Spectrometer Outperforms State-Of-The-Art Models

Mass spectrometry is a precise technique for identifying the chemical components of a sample and has significant potential for monitoring chronic illness health states, such as measuring hormone levels... Read more

Hematology

view channel
Image: The CAPILLARYS 3 DBS devices have received U.S. FDA 510(k) clearance (Photo courtesy of Sebia)

Next Generation Instrument Screens for Hemoglobin Disorders in Newborns

Hemoglobinopathies, the most widespread inherited conditions globally, affect about 7% of the population as carriers, with 2.7% of newborns being born with these conditions. The spectrum of clinical manifestations... Read more

Immunology

view channel
Image: The novel test uses an existing diagnostic procedure as its basis to target the Epstein Barr Virus (Photo courtesy of 123RF)

Blood Test Measures Immune Response to Epstein-Barr Virus in MS Patients

Multiple sclerosis (MS) is a chronic neurological condition for which there is currently no cure. It affects around three million people globally and ranks as the second most common cause of disability... Read more

Microbiology

view channel
Image: The T-SPOT.TB test is now paired with the Auto-Pure 2400 liquid handling platform for accurate TB testing (Photo courtesy of Shutterstock)

Integrated Solution Ushers New Era of Automated Tuberculosis Testing

Tuberculosis (TB) is responsible for 1.3 million deaths every year, positioning it as one of the top killers globally due to a single infectious agent. In 2022, around 10.6 million people were diagnosed... Read more

Pathology

view channel
Image: Insulin proteins clumping together (Photo courtesy of Jacob Kæstel-Hansen)

AI Tool Detects Tiny Protein Clumps in Microscopy Images in Real-Time

Over 55 million individuals worldwide suffer from dementia-related diseases like Alzheimer's and Parkinson's. These conditions are caused by the clumping together of the smallest building blocks in the... Read more
Copyright © 2000-2024 Globetech Media. All rights reserved.